v3.26.3
Fair Value Disclosures (Tables)
9 Months Ended
Sep. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured to Fair Value on Recurring Basis
The table below presents the fair values of certain financial assets and liabilities that are measured at fair value on a recurring basis in the Company's financial statements (in thousands).
DescriptionSeptember 30,
2026
December 31,
2025
Assets:
Values based on Level 1 inputs:
Deferred compensation plan assets(1)
$18,545 $19,188 
Total Level 1 inputs18,545 19,188 
Values based on Level 2 inputs:
Deferred compensation plan assets(1)
166,976 155,949 
Foreign currency forward contracts(2)
8 1,169 
Total Level 2 inputs166,984 157,118 
Total Assets$185,529 $176,306 
Liabilities:
Values based on Level 2 inputs:
Deferred compensation plan liabilities(1)
$192,857 $178,331 
Foreign currency forward contracts(2)
149 939 
Total Level 2 inputs193,006 179,270 
Total Liabilities$193,006 $179,270 
(1)The Company has a deferred compensation plan for the benefit of certain highly compensated officers, managers and other key employees. The assets consist of investments in money market funds, mutual funds and company-owned life insurance contracts, which are valued based on Level 1 or Level 2 inputs. The related deferred compensation plan liabilities are recorded at fair value, or the estimated amount needed to settle the liability, which the Company considers to be a Level 2 input.
(2)The Company enters into foreign currency forward exchange contracts to hedge the effects of adverse fluctuations in foreign currency exchange rates (see Note 11 — Derivatives and Hedging). Valuation of these contracts is based on observable foreign currency exchange rates in active markets, which the Company considers to be a Level 2 input.
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments
The table below presents the carrying amounts (net of deferred financing costs) and fair values of financial instruments that are not recorded at fair value in the Company’s Condensed Consolidated Balance Sheets (in thousands). The estimated fair value of the financial instruments was derived from quoted market prices provided by an independent dealer, which the Company considers to be a Level 2 input.
Carrying AmountFair Value
September 30,December 31,September 30,December 31,
Description2026202520262025
2028 Notes$797,552 $796,563 $779,992 $798,080 
2029 Notes597,283 596,578 560,184 578,760 
2030 Notes795,750 795,024 723,160 759,224 
2031 Notes347,003 346,564 330,852 351,869 
2035 Notes445,676 445,411 407,102 450,657 
Total$2,983,264 $2,980,140 $2,801,290 $2,938,590